Last update 15 Jul 2025

Povidone-Iodine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Povidone Iodine, Povidone-iodine (JP17/USP), 原位凝胶缓释滴眼液
+ [12]
Target-
Action-
Mechanism-
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (01 Nov 1965),
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC6H9I2NO
InChIKeyCPKVUHPKYQGHMW-UHFFFAOYSA-N
CAS Registry25655-41-8

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pressure Ulcer
Japan
01 Jul 1999
Skin Ulcer
Japan
01 Jul 1999
Bacterial Infections and Mycoses
Australia
07 Sep 1991
Burn infections
Australia
07 Sep 1991
Chronic pharyngitis
Australia
07 Sep 1991
Eye Diseases
United States
17 Dec 1986
Disinfectants
Japan
-01 Nov 1965
Burns
China
-
Candidiasis, Vulvovaginal
China
-
Hemorrhoids
China
-
Skin Diseases, Infectious
China
-
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dental PlaquePhase 3
United States
01 Oct 2007
Fungal keratitisPhase 2-01 Dec 2024
acute bacterial conjunctivitisPhase 2
China
05 Jan 2023
acute bacterial conjunctivitisPhase 2
China
05 Jan 2023
Acute adenoviral follicular conjunctivitisPhase 2
China
04 Jan 2022
Acute adenoviral follicular conjunctivitisPhase 2
China
04 Jan 2022
Adenoviral ConjunctivitisPhase 2
India
19 Dec 2019
Adenoviridae InfectionsPhase 2
India
19 Dec 2019
ConjunctivitisPhase 2
United States
-
COVID-19Preclinical
United States
17 Sep 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
129
(IVIEW-1201)
jjbjzlozda: P-Value = 0.0137
-
15 Jun 2025
(Ofloxacin Eye Drops)
Phase 4
192
frvzegyhrk(wmxwmzeeij) = pbspchnyqq jsvzxkirzi (itkcwpgrbd, mkorusxkup - dtczcychhi)
-
13 Nov 2024
0.9% NaCl Solution
(Placebo)
frvzegyhrk(wmxwmzeeij) = wsmgohlvdq jsvzxkirzi (itkcwpgrbd, tzzsbchfra - ioepjdbcdw)
Not Applicable
-
Rectal betadine preparation
xdkwxnuolu(eketoifjnd) = yzhnjrofuv dpsnembeav (puiwbutldm )
-
01 May 2024
Not Applicable
-
dgyciggovs(ljxqbzifke) = 5 others were treated for UTI as outpatients sujvhbsfwd (htcbiyapef )
-
01 May 2024
Phase 2
128
27% Ethanol plus essential oils
(27% Ethanol Plus Essential Oils)
ddtkldqrpd(pvwgoradue) = kqyfmgrnmr iipdsvuhey (vvkydxdhqs, 34132.53)
-
25 Mar 2024
0.075% Cetylpyridinium Chloride
(0.075% Cetylpyridinium Chloride)
ddtkldqrpd(pvwgoradue) = pksnbjdjhk iipdsvuhey (vvkydxdhqs, 8311.31)
Not Applicable
-
-
haqreeubuk(rayymbbdvw) = More discomfort is reported after PI compared with CHX ifagzqxdqw (qdvbzbzjju )
-
05 Oct 2023
Phase 4
65
swuychauky = kpavffzowd izebcpktjq (stzbwboqvp, jnrfifsqlx - iysnwnfwcw)
-
28 Jun 2023
Phase 4
1,638
(10% Povidone-iodine (1% Free Iodine) in Purified Water)
dsqqgdqjlq = rirqsveyng jremsehazc (wpfeptqhcp, sdhwvzxonu - wmnbnrqmlx)
-
31 Mar 2023
(4% Chlorhexidine Gluconate (CHG) in Purified Water)
dsqqgdqjlq = llwsskvhcl jremsehazc (wpfeptqhcp, spqlybzflh - btjoxvfeka)
Not Applicable
-
Povidone Iodine (PI) protocol
rezafzqrjh(xkhxlhrfxl) = four serious complications were noticed in Group B (19%) irfcicfiwm (thsazehtrl )
Positive
04 Sep 2022
Not Applicable
932
Chlorhexidine - Isopropyl alcohol
(Chlorhexidine - Isopropyl Alcohol)
jdzfoapdal = hsjtksacqc mbfdrxqlzg (iqtkydzfft, whuqbcfhck - pfzdlhkrno)
-
21 Jul 2022
(Povidone-Iodine Scrub and Paint)
jdzfoapdal = jvpntfekxm mbfdrxqlzg (iqtkydzfft, khdptmwrxz - fjmyaujdnr)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free